Methods and compositions for reducing muscle loss and/or inhibiting sarcopenia associated with weight loss in mammals via administration of a composition comprising an egg yolk derived product are disclosed. In one nonlimiting embodiment, the muscle loss and/or sarcopenia results from a weight loss drug such as semaglutide or tirzepatide.
Methods for managing and/or alleviating one or more symptoms of a muscular dystrophy or other genetic condition associated with a muscular disorder via administering a composition of egg yolk derived product are provided.
A23J 1/08 - Obtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from eggs
A23J 1/09 - Obtaining protein compositions for foodstuffsBulk opening of eggs and separation of yolks from whites from eggs separating yolks from whites
A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
C07K 16/02 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies from eggs
3.
Methods and Compositions for Managing and/or Alleviating Symptoms of Muscular Dystrophies and Other Genetic Muscular Disorders
Methods for managing and/or alleviating one or more symptoms of a muscular dystrophy or other genetic condition associated with a muscular disorder via administering a composition of egg yolk derived product are provided.
Myogenic compounds identified in egg yolk and synthetic derivatives thereof, nutraceutical compositions of one or more of these myogenic compounds and synthetic derivatives thereof and use of these compounds and nutraceutical compositions in increasing muscle mass in mammals are provided.
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
Methods and compositions for increasing lean muscle mass or decreasing loss of lean muscle mass in mammals suffering from chronic kidney disease via administration of a composition of egg yolk derived product without aggravating the chronic kidney disease are provided.
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
9.
METHODS AND COMPOSITIONS FOR REDUCING MUSCLE LOSS AND/OR INHIBITING SARCOPENIA ASSOCIATED WITH WEIGHT LOSS
Methods and compositions for reducing muscle loss and/or inhibiting sarcopenia associated with weight loss in mammals via administration of a composition comprising an egg yolk derived product are disclosed. In one nonlimiting embodiment, the muscle loss and/or sarcopenia results from a weight loss drug such as semaglutide or tirzepatide.
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
Methods and compositions for increasing lean muscle mass or decreasing loss of lean muscle mass in mammals suffering from chronic kidney disease via administration of a composition of egg yolk powder without aggravating the chronic kidney disease are provided.
A61P 13/12 - Drugs for disorders of the urinary system of the kidneys
A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
15.
COMPOSITIONS AND METHODS FOR PRODUCING NON-HUMAN TISSUE ENGINEERED MEAT PRODUCTS
Methods for producing a non-human meat products in a culture media containing egg yolk powder and culture media containing egg yolk powder are provided.
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
Myogenic compounds identified in egg yolk and synthetic derivatives thereof, nutraceutical compositions of one or more of these myogenic compounds and synthetic derivatives thereof and use of these compounds and nutraceutical compositions in increasing muscle mass in mammals are provided.
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
Composition containing egg yolk powder and a second muscle enhancing product for use in enhancing muscle growth and slowing muscle degeneration in mammals are provided. Embodiments of the present invention are generally related to muscle enhancing products. More specifically, embodiments of the present invention relate to egg-based products in combination with one or more muscle enhancing products, and methods of manufacturing and use of the same.
05 - Pharmaceutical, veterinary and sanitary products
Goods & Services
(1) Dietary supplements, namely, dietary supplements to promote healthy bones, joints and muscles, dietary supplements used for energy stimulation, dietary supplements for reducing muscle inflammation, dietary supplements for general health and well being; nutritional supplements, namely, nutritional supplements to promote healthy bones, joints and muscles, nutritional supplements used for energy stimulation, nutritional supplements for reducing muscle inflammation, nutritional supplements for general health and well being; dietary supplements, namely, dietary supplements for animals to promote healthy bones, joints and muscles, dietary supplements for animals used for energy stimulation, dietary supplements for animals for reducing muscle inflammation, dietary supplements for animals for general health and well being; nutritional supplements, namely, nutritional supplements for animals to promote healthy bones, joints and muscles, nutritional supplements for animals used for energy stimulation, nutritional supplements for animals for reducing muscle inflammation, nutritional supplements for animals for general health and well being.
22.
Methods and compositions for improving quality of life and increasing activity in aging and chronically ill mammals
Methods for improving quality of life and/or increasing activity in an aging and/or chronically ill mammal via administration of a composition of egg powder protein are provided.
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
03 - Cosmetics and toiletries; cleaning, bleaching, polishing and abrasive preparations
05 - Pharmaceutical, veterinary and sanitary products
31 - Agricultural products; live animals
Goods & Services
Animal care products other than for veterinary use; shampoos for animals; soaps for animals; cosmetics for animals; toiletries for care of skin and fur of animals; topical creams and lotions for animals; dentifrices for animals; deodorising preparations for use on animals; aromatic compositions for animal use. Pharmaceutical and veterinary preparations for animals; animal care products for veterinary use; dietetic substances adapted for veterinary use for animals; dietary and/or nutritional supplements for animals; complete foods for animals adapted for veterinary purposes; additives and/or supplements for animals, for animal feed, for joint care in animals, for muscle care in animals, for skin or fur care of animals, for calming in animals and/or to aid digestion in animals; medicated foodstuffs for animals; vitamin and/or mineral preparations for animals; nutritional, pharmaceutical, veterinary, or dietary products for muscle building in animals; products to reduce muscle loss in animals; joint care products for animals; medicated skin and/or fur treatments for animals, washes, topical creams /or lotions for animals; plasters, materials for dressings for animals; materials for stopping teeth and dental wax for animals; sanitary preparations for medical purposes for animals; disinfectants; deodorant preparations for absorbing animal odours; anti-parasitic collars and other anti-parasitic items adapted for wear by animals; antiparasitic products for animals; medicated products for oral use in animals; calming products for animals; digestion aid products for animals; pheromones for veterinary use; bacteria for animal consumption for use in maintaining normal health; pharmaceutical preparations for humans; vitamin and/or mineral preparation for humans; dietary and/or nutritional supplements for humans; medicinal ,and nutritional preparations for humans; additives and/or supplements for humans, for joint care in humans, for muscle care in humans and/or for skin care of humans. Food and beverages for animals; animal nutrition products; foodstuffs for animals; animal feed; complete food for animals; complete foods for animals for muscle care; complete foods for animals for muscle building; complete foods for animals to reduce muscle loss; complete foods for animals for muscle care, joint care skin and/or fur care; complete foods for animals to aid digestion; complete food for animals for calming; bones and other animal derivatives for consumption by animals; algae for animal consumption; animal litter, animal bedding and nesting material.
Compositions containing egg yolk powder and a NAD+ precursor and/or pterostilbene and/or an agent promoting mitochondrial rejuvenation for use in enhancing overall health and longevity in mammals are provided.
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
A61K 31/085 - Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
26.
METHODS FOR ALLEVIATING POST-POLIO MUSCLE WEAKNESS AND CONDITIONS SIMILAR THERETO
Methods for alleviating, reversing or inhibiting one or more symptom of post-polio syndrome via administration of a composition comprising egg yolk powder are provided.
Methods for improving quality of life and/or increasing activity in an aging and/or chronically ill mammal via administration of a composition of egg yolk powder are provided. In some embodiments, additional agents improving quality of life and/or increasing activity in an aging and/or chronically ill mammal are administered in combination with the egg yolk powder.
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
28.
Methods and compositions for improving skeletal muscle protein fractional synthetic rate
Methods and egg yolk powder containing compositions for improving skeletal muscle protein fractional synthetic rate (FSR) in mammals and inhibiting or reversing sarcopenia are provided.
Methods for improving quality of life and/or increasing activity in an aging and/or chronically ill mammal via administration of a composition of egg powder protein are provided.
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
30.
Methods and compositions for improving skeletal muscle protein fractional synthetic rate
Methods and egg yolk powder containing compositions for improving skeletal muscle protein fractional synthetic rate (FSR) in mammals and inhibiting or reversing sarcopenia are provided.
A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Processes for production of a composition containing active follistatin via spray/heat drying of a biological source containing follistatin as well as compositions containing this active follistatin and methods it use increasing muscle mass are provided.
Methods for alleviating one or more symptoms and/or inhibiting muscle disuse atrophy in mammals via administration of compositions of egg powder protein are provided.
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system
A process for producing a composition from a biological source, which composition is preserved and, especially pathogen free and is storage stable, preferably at room temperature. Embodiments of the invention provide a process for producing a composition from eggs.
A23L 3/015 - Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with pressure variation, shock, acceleration or shear stress
A23P 10/30 - Encapsulation of particles, e.g. foodstuff additives
A23L 15/00 - Egg productsPreparation or treatment thereof
A23L 5/30 - Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
A23P 10/40 - Making free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
A23D 9/013 - Other fatty acid esters, e.g. phosphatides
C07K 14/47 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates from mammals
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A23L 3/32 - Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with electric currents without heating effect
Described herein are avian follistatin products, and methods for producing such products, in which such products are effective for a variety of conditions, including increasing muscle mass. Avian follistatin products described herein are packaged as dietary supplements or nutritional supplements are useful in muscle regeneration.
A23L 15/00 - Egg productsPreparation or treatment thereof
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A process for producing a composition from a biological source, which composition is preserved and, especially pathogen free and is storage stable, preferably at room temperature. Embodiments of the invention provide a process for producing a composition from eggs.
A23L 3/015 - Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with pressure variation, shock, acceleration or shear stress
A23L 5/30 - Physical treatment, e.g. electrical or magnetic means, wave energy or irradiation
A23L 15/00 - Egg productsPreparation or treatment thereof
A23L 3/32 - Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with electric currents without heating effect
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A23P 10/30 - Encapsulation of particles, e.g. foodstuff additives
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
C07K 14/47 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates from mammals
A23D 9/013 - Other fatty acid esters, e.g. phosphatides
A23P 10/40 - Making free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
Embodiments of the present invention are generally related to methods of obtaining effective amount of avian follistatin. More specifically, embodiments of the present invention relate to products comprising avian follistatin, and methods of optimizing the same based on avian follistatin concentrations utilized during the manufacturing process. In one embodiment of the present invention, a method of creating a consumable product for treatment of a muscle degenerating disease having avian follistatin comprises selecting an avian egg based upon a desired threshold of avian follistatin concentration therein; extracting material from the avian egg, the material comprising avian follistatin; and processing the material with one or more excipients to yield the consumable product.
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A61K 35/57 - BirdsMaterials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
A process for producing a composition containing biologically active follistatin from a biological source, which composition is preserved and, especially pathogen free and is storage stable, preferably at room temperature. Further, the invention relates to the composition containing biologically active follistatin, which composition is available by the production process. The invention provides a process for producing a composition containing biologically active follistatin from avian eggs, or from raw animal blood serum.
A61K 38/17 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans
A23L 3/015 - Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with pressure variation, shock, acceleration or shear stress
A23L 3/32 - Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with electric currents without heating effect
A61K 35/56 - Materials from animals other than mammals
C07K 14/47 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from animalsPeptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from humans from vertebrates from mammals
